WELL Health vs. Docebo: Better Tech Stock to Buy Right Now?

Let’s look at the recent performances and growth prospects of Well Health and Docebo to identify a better buy.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canadian equity markets have rebounded strongly over the last few weeks amid easing recession fears, with the S&P/TSX Composite Index rising 9.9% higher this year. Amid improving investors’ optimism, let’s assess which of WELL Health Technologies (TSX:WELL) and Docebo (TSX:DCBO) would be a better tech stock to buy now based on their recent quarterly performances and growth prospects.

WELL Health Technologies

Earlier this month, WELL Health reported an impressive second-quarter performance, with its top line growing by 42% to $243.1 million. An organic growth of 21% and acquisitions over the last four quarters drove its sales. It witnessed solid performances across its three segments. During the quarter, it had 1.4 million patient visits and 2.1 million patient interactions, representing a year-over-year growth of 38% and 48%, respectively.

Created with Highcharts 11.4.3Well Health Technologies PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Amid the top-line growth, its adjusted gross profits increased by 18% to $107.4 million. However, its gross profit margin declined from 53.1% to 44.2% amid the acquisition of lower-margin businesses. Further, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) increased by 11%, while adjusted EBITDA to WELL shareholders grew by 3%. It also generated $35.2 million of cash from its operations, thus helping it to pay off $14 million of debt, lowering its leverage ratio to 2.67.

Meanwhile, I expect the uptrend in WELL Health’s financials to continue amid its expanding addressable market and growth initiatives. The increased usage of virtual services, digitization of patient records, and adoption of software solutions in the healthcare segment have expanded its addressable market. The company is implementing advanced artificial intelligence tools, patient engagement technologies, and digital workflow integration, which could grow its market share and drive its financials in the coming years. It has also adopted several cost-cutting initiatives, which could improve its profitability.

Docebo

Docebo also reported an impressive second-quarter performance earlier this month, beating its guidance. Its topline grew by 22% to $53.1 million. The addition of 307 customers over the last four quarters and an increase of 9.7% in its average contract value drove its financials. Supported by its top-line growth, its adjusted EPS (earnings per share) grew by 85.7% to $0.26. The company also generated free cash flows of $8.45 million during the quarter, representing a 20% year-over-year increase.

Created with Highcharts 11.4.3Well Health Technologies PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

The usage of digital learning tools in academics and businesses is growing, thus expanding Docebo’s addressable market. Meanwhile, the company is introducing artificial intelligence-powered features to enhance its customers’ experience. The company has signed long-term agreements with its customers, providing financial stability. Amid its solid second-quarter performance and growth initiatives, the company’s management expects its 2024 top line to grow 18-19% while its adjusted EBITDA margin could be around 15-15.5%.

Investors’ takeaway

Supported by its solid performances, WELL Health is up 19.2% this year, outperforming the broader equity markets. Despite its strong returns, the company trades at an attractive valuation, with its next-12-month price-to-earnings multiple at 16.8.

Meanwhile, Docebo has underperformed the broader equity markets this year, with its stock price losing 9.1%. Despite the decline in stock price, the company’s valuation looks expensive, with its NTM price-to-earnings multiple standing at 38.2. Although both companies offer high growth prospects, I am more bullish on WELL Health due to its cheaper valuation.

Should you invest $1,000 in Ct Real Estate Investment Trust right now?

Before you buy stock in Ct Real Estate Investment Trust, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Ct Real Estate Investment Trust wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends Docebo. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

Canada day banner background design of flag
Dividend Stocks

Top Canadian Stocks to Buy Right Now With $5,000

Looking for some safe, long-term stocks? These Canadian stocks are where you should look first.

Read more »

money goes up and down in balance
Investing

Where I’d Invest $5,000 in 5 Cheap Canadian Stocks for Value and Growth

$5,000 can buy five cheap Canadian stocks offering both value and price appreciation in 2025.

Read more »

cloud computing
Investing

Got $5,000 to Invest? 3 Insurance Stocks to Buy and Hold Forever

Insurance stocks have been great long-term investments. Here are three top stocks to add if the market pulls back.

Read more »

Happy shoppers look at a cellphone.
Tech Stocks

1 Tech Stock I’d Buy With $1,000 Whenever it Dips (Further) in Price

Shopify (TSX:SHOP) is one of the names to check out should it fall below $100 per share.

Read more »

Car, EV, electric vehicle
Dividend Stocks

Outlook for Magna Stock in 2025

Magna stock has sunk into the toilet, but it could now be one of the best undervalued stocks out there.

Read more »

alcohol
Dividend Stocks

Why I’d Consider These 3 Blue-Chip Dividend Stocks for a $20,000 Lifelong Investment

In a market correction, it’s essential to focus on blue-chip stocks that offer stability and long-term growth potential.

Read more »

Canadian dollars are printed
Dividend Stocks

Transform Your TFSA Into a Cash-Creating Machine With $14,000

Investing a total of $14,000 across these three stocks could earn you more than $1,039 in tax-free income each year.

Read more »

coins jump into piggy bank
Dividend Stocks

Where I’d Invest $12,000 in Canadian Stocks for Reliable Dividends

Want reliable dividends? Here's a trio of stocks that can provide a juicy income stacked for growth, even with a…

Read more »